Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic

Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular events. This study aimed to assess the frequency of inappropriate medication dosages (IMD) for cardiovascular disease prevention among patients with CKD and its predictors in an urban academic primary care clinic in S...

Full description

Bibliographic Details
Main Authors: Jazlan Jamaluddin, Mohamed-Syarif Mohamed-Yassin, Siti Nuradliah Jamil, Mohd Azzahi Mohamed Kamel, Mohamad Ya'akob Yusof
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023022053
_version_ 1797837063938113536
author Jazlan Jamaluddin
Mohamed-Syarif Mohamed-Yassin
Siti Nuradliah Jamil
Mohd Azzahi Mohamed Kamel
Mohamad Ya'akob Yusof
author_facet Jazlan Jamaluddin
Mohamed-Syarif Mohamed-Yassin
Siti Nuradliah Jamil
Mohd Azzahi Mohamed Kamel
Mohamad Ya'akob Yusof
author_sort Jazlan Jamaluddin
collection DOAJ
description Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular events. This study aimed to assess the frequency of inappropriate medication dosages (IMD) for cardiovascular disease prevention among patients with CKD and its predictors in an urban academic primary care clinic in Selangor, Malaysia. All patients who attended the clinic from April to June 2019 and fulfilled the inclusion criteria were included in this cross-sectional study, except for those with an estimated glomerular filtration rate (eGFR) of more than 90 ml/min, diagnosed with urinary tract infection, pregnant or were on dialysis for end stage renal disease. Their prescriptions on the electronic medical record (EMR) system were evaluated for appropriateness using the dose adjustment recommendations based on the 2018 Malaysian Clinical Practice Guidelines on management of CKD. A total of 362 medical records were included in this study. 16.6% (95% Confidence Interval [CI]: 12.9–20.8) or 60 out of 362 of the patient records analysed contained medications prescribed with inappropriate dosages. Patients with higher stages of CKD were associated with higher odds of IMD, namely CKD stage G3b (adjusted Odds Ratio [aOR] 10.41; 95% CI: 2.31–46.88) and CKD stage 4–5 (aOR 15.76; 95% CI: 3.22–77.28). Other predictors of IMD were diagnosis of diabetes mellitus (aOR 6.40; 95% CI: 2.15–19.01), number of prescribed medications of 5 or more (aOR 4.69; 95% CI: 1.55–14.20), and eGFR reduction of more than 25% over one year (aOR 2.82; 95% CI: 1.41–5.65). Within the limitations of this study, we conclude that the occurrence of IMD for CVD prevention was low in CKD patients in this primary care clinic. Medications with inappropriate dosages identified in this study include simvastatin, fenofibrate, hydrochlorothiazide, spironolactone, metformin, gliclazide, sitagliptin, dapagliflozin and empagliflozin. Clinicians should consider the predictors of inappropriate medication dosages listed above when prescribing to patients with CKD to reduce the risk of medications-related toxicities and adverse effects. Limitations of this study should be considered when interpreting the findings presented.
first_indexed 2024-04-09T15:18:49Z
format Article
id doaj.art-f09980b7af334b2caaa7d2a03a0c91e9
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-09T15:18:49Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-f09980b7af334b2caaa7d2a03a0c91e92023-04-29T14:53:27ZengElsevierHeliyon2405-84402023-04-0194e14998Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinicJazlan Jamaluddin0Mohamed-Syarif Mohamed-Yassin1Siti Nuradliah Jamil2Mohd Azzahi Mohamed Kamel3Mohamad Ya'akob Yusof4Klinik Kesihatan Sauk, Sauk, Kuala Kangsar, Perak, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Jalan Hospital, Sungai Buloh 47000, Selangor, Malaysia; Corresponding author.Klinik Kesihatan Pasir Gudang, Johor Bahru, Johor, MalaysiaKlinik Kesihatan Padang Rengas, Padang Rengas, Kuala Kangsar, Perak, MalaysiaDepartment of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Jalan Hospital, Sungai Buloh 47000, Selangor, MalaysiaPatients with chronic kidney disease (CKD) are at increased risk of cardiovascular events. This study aimed to assess the frequency of inappropriate medication dosages (IMD) for cardiovascular disease prevention among patients with CKD and its predictors in an urban academic primary care clinic in Selangor, Malaysia. All patients who attended the clinic from April to June 2019 and fulfilled the inclusion criteria were included in this cross-sectional study, except for those with an estimated glomerular filtration rate (eGFR) of more than 90 ml/min, diagnosed with urinary tract infection, pregnant or were on dialysis for end stage renal disease. Their prescriptions on the electronic medical record (EMR) system were evaluated for appropriateness using the dose adjustment recommendations based on the 2018 Malaysian Clinical Practice Guidelines on management of CKD. A total of 362 medical records were included in this study. 16.6% (95% Confidence Interval [CI]: 12.9–20.8) or 60 out of 362 of the patient records analysed contained medications prescribed with inappropriate dosages. Patients with higher stages of CKD were associated with higher odds of IMD, namely CKD stage G3b (adjusted Odds Ratio [aOR] 10.41; 95% CI: 2.31–46.88) and CKD stage 4–5 (aOR 15.76; 95% CI: 3.22–77.28). Other predictors of IMD were diagnosis of diabetes mellitus (aOR 6.40; 95% CI: 2.15–19.01), number of prescribed medications of 5 or more (aOR 4.69; 95% CI: 1.55–14.20), and eGFR reduction of more than 25% over one year (aOR 2.82; 95% CI: 1.41–5.65). Within the limitations of this study, we conclude that the occurrence of IMD for CVD prevention was low in CKD patients in this primary care clinic. Medications with inappropriate dosages identified in this study include simvastatin, fenofibrate, hydrochlorothiazide, spironolactone, metformin, gliclazide, sitagliptin, dapagliflozin and empagliflozin. Clinicians should consider the predictors of inappropriate medication dosages listed above when prescribing to patients with CKD to reduce the risk of medications-related toxicities and adverse effects. Limitations of this study should be considered when interpreting the findings presented.http://www.sciencedirect.com/science/article/pii/S2405844023022053Chronic kidney diseaseInappropriate prescribingCardiovascular diseasePreventive health servicesPrimary health careMalaysia
spellingShingle Jazlan Jamaluddin
Mohamed-Syarif Mohamed-Yassin
Siti Nuradliah Jamil
Mohd Azzahi Mohamed Kamel
Mohamad Ya'akob Yusof
Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
Heliyon
Chronic kidney disease
Inappropriate prescribing
Cardiovascular disease
Preventive health services
Primary health care
Malaysia
title Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
title_full Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
title_fullStr Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
title_full_unstemmed Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
title_short Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
title_sort frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients a retrospective cross sectional study in a malaysian primary care clinic
topic Chronic kidney disease
Inappropriate prescribing
Cardiovascular disease
Preventive health services
Primary health care
Malaysia
url http://www.sciencedirect.com/science/article/pii/S2405844023022053
work_keys_str_mv AT jazlanjamaluddin frequencyandpredictorsofinappropriatemedicationdosagesforcardiovasculardiseasepreventioninchronickidneydiseasepatientsaretrospectivecrosssectionalstudyinamalaysianprimarycareclinic
AT mohamedsyarifmohamedyassin frequencyandpredictorsofinappropriatemedicationdosagesforcardiovasculardiseasepreventioninchronickidneydiseasepatientsaretrospectivecrosssectionalstudyinamalaysianprimarycareclinic
AT sitinuradliahjamil frequencyandpredictorsofinappropriatemedicationdosagesforcardiovasculardiseasepreventioninchronickidneydiseasepatientsaretrospectivecrosssectionalstudyinamalaysianprimarycareclinic
AT mohdazzahimohamedkamel frequencyandpredictorsofinappropriatemedicationdosagesforcardiovasculardiseasepreventioninchronickidneydiseasepatientsaretrospectivecrosssectionalstudyinamalaysianprimarycareclinic
AT mohamadyaakobyusof frequencyandpredictorsofinappropriatemedicationdosagesforcardiovasculardiseasepreventioninchronickidneydiseasepatientsaretrospectivecrosssectionalstudyinamalaysianprimarycareclinic